Hair TransplantationCO2-FUE-PRPNCT07751523
Fractional CO₂ Laser Before Follicular Unit Extraction Hair Transplantation With Platelet-Rich Plasma for Secondary Cicatricial Alopecia
A study testing hair transplantation preceded by fractional and PRP in people with Hair Transplantation, run by Tanta University at 1 site in Egypt.
Trial summary
Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and… Read more about this study
- Who is it for?
- Ages 16 to 30 years
- Conditions the study is for
- Hair Transplantation
- What is being tested?
- hair transplantation preceded by fractional and PRP
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 20 participants
- Where
- 1 siteEgypt
- Study dates
- 2 May 2024to 30 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 30 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Patients with stable secondary cicatricial alopecia. Male or female participants. Participants with realistic expectations regarding treatment outcomes. All hair types (silky, curly, or normal hair). Presence of an adequate donor site for follicular unit extraction (FUE). Ability and willingness to provide written informed consent.
Who cannot join
- Extremes of age. Chronic systemic diseases, including hepatic or renal disease. Receiving chemotherapy or systemic corticosteroid therapy. Platelet disorders or other blood disorders. Pregnancy or lactation. History of keloid formation. Scar duration less than 1 year. Absence of a suitable donor site for hair transplantation
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Preoperative Fractional CO₂ Laser on the Outcome of Follicular Unit Extraction Hair Transplantation Combined With Intraoperative Platelet-Rich Plasma in Patients With Secondary Cicatricial Alopecia
Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and fibrosis within scar tissue. Fractional carbon dioxide (CO₂) laser has been proposed to improve the recipient site by enhancing tissue remodeling and vascularization before transplantation.
This prospective comparative clinical study evaluated the effect of three preoperative sessions of fractional CO₂ laser followed by FUE hair transplantation with intraoperative platelet-rich plasma (PRP) injection compared with FUE hair transplantation combined with intraoperative PRP alone in patients with stable secondary cicatricial alopecia. Twenty participants were allocated into two groups of 10 patients each and were followed for 9 months after hair transplantation.
The primary objective was to determine whether preoperative fractional CO₂ laser improves the clinical outcome of FUE hair transplantation in secondary cicatricial alopecia. Outcomes included clinical improvement, dermoscopic assessment of hair growth, patient satisfaction, and scar assessment.
Read the detailed description
Secondary cicatricial alopecia is characterized by permanent destruction of hair follicles resulting from trauma, burns, infection, radiation, or other non-follicular pathological processes. Hair transplantation using follicular unit extraction (FUE) is an established surgical treatment for stable secondary cicatricial alopecia; however, graft survival and cosmetic outcomes may be compromised by fibrosis, reduced vascularity, and poor tissue elasticity within scarred recipient sites. Fractional carbon dioxide (CO₂) laser has been suggested to improve scar quality by promoting tissue remodeling, neovascularization, and wound healing, potentially enhancing the recipient bed before hair transplantation. Platelet-rich plasma (PRP), which contains a high concentration of growth factors, may further improve graft survival and hair growth by stimulating tissue regeneration.
This prospective comparative clinical study was conducted to evaluate whether preoperative fractional CO₂ laser treatment improves the outcome of FUE hair transplantation combined with intraoperative PRP injection in patients with stable secondary cicatricial alopecia. Twenty participants of both sexes with stable secondary cicatricial alopecia and realistic treatment expectations were enrolled. Patients with chronic systemic diseases, pregnancy or lactation, platelet or blood disorders, history of keloid formation, scar duration less than one year, or inadequate donor sites were excluded. The study was approved by the Research Ethics Committee of Tanta University Hospitals (Approval No. 34430/1/21), and written informed consent was obtained from all participants before enrollment.
Participants were assigned into two treatment groups. Group A received three sessions of fractional CO₂ laser treatment at one-month intervals before surgery, followed one month later by FUE hair transplantation combined with intraoperative PRP injection. Group B underwent direct FUE hair transplantation combined with intraoperative PRP injection without preoperative laser treatment. PRP was prepared from autologous venous blood using a double-centrifugation technique and injected into the recipient scar tissue during the transplantation procedure. Hair grafts were harvested using the FUE technique from the donor area and transplanted into the scarred recipient site according to standard surgical protocols.
Participants were followed for nine months after hair transplantation. Clinical assessment included standardized photographic evaluation by three blinded dermatologists and two plastic surgeons. Dermoscopic examination was performed before and after treatment to evaluate follicular regeneration and the percentage of scar surface covered by growing hair. Patient satisfaction and scar severity were also assessed using validated scar assessment scales. The primary objective was to determine whether preoperative fractional CO₂ laser enhances the clinical outcome of FUE hair transplantation with intraoperative PRP in patients with secondary cicatricial alopecia. Secondary objectives included evaluation of dermoscopic hair regrowth, patient satisfaction, and changes in scar assessment scores
- Conditions
- Hair Transplantation
- Being tested
- hair transplantation preceded by fractional and PRP
- Keywords
- cicatricial alopecia, fractional CO2, PRP, Hair Transplantation
- Medical subject headings
- Alopecia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
hair transplantation preceded by fractional and PRPProcedure or surgery
intervention injection
| Study group | Role | What they receive |
|---|---|---|
| fractional plus hair transplantation and PRP | Active comparator | Treatment injection Receives: Procedure: hair transplantation preceded by fractional and PRP |
| Hair transplantation plus PRP | Placebo comparator | PLACEBO Receives: Procedure: hair transplantation preceded by fractional and PRP |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical improvement after hair transplantation
Excellent (>75% improvement) Good (50-75%) Fair (25-49%) Poor (<25%)
Measured: 9 months after follicular unit extraction (FUE) hair transplantation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2026
- Study start2 May 2024
- Primary completion10 Jan 2026
- Study completion30 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hair TransplantationStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sarah Hamdy Soliman, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07751523
- Sponsor's protocol ID
- 34430/1/21
- Acronym
- CO2-FUE-PRP
- Status last verified
- Aug 2026
- First submitted
- 3 Aug 2026
- Last updated
- 7 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Preoperative Fractional CO₂ Laser on the Outcome of Follicular Unit Extraction Hair Transplantation Combined With Intraoperative Platelet-Rich Plasma in Patients With Secondary Cicatricial Alopecia
- ClinicalTrials.gov ID
- NCT07751523
- Acronym / sponsor ID
- CO2-FUE-PRP / 34430/1/21
- Conditions
- Hair Transplantation
- Keywords
- cicatricial alopecia, fractional CO2, PRP, Hair Transplantation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 2 May 2024 (actual)
- Primary completion
- 10 Jan 2026 (actual)
- Study completion
- 30 May 2026 (actual)
- First posted
- 7 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and fibrosis within scar tissue. Fractional carbon dioxide (CO₂) laser has been proposed to improve the recipient site by enhancing tissue remodeling and vascularization before transplantation.
This prospective comparative clinical study evaluated the effect of three preoperative sessions of fractional CO₂ laser followed by FUE hair transplantation with intraoperative platelet-rich plasma (PRP) injection compared with FUE hair transplantation combined with intraoperative PRP alone in patients with stable secondary cicatricial alopecia. Twenty participants were allocated into two groups of 10 patients each and were followed for 9 months after hair transplantation.
The primary objective was to determine whether preoperative fractional CO₂ laser improves the clinical outcome of FUE hair transplantation in secondary cicatricial alopecia. Outcomes included clinical improvement, dermoscopic assessment of hair growth, patient satisfaction, and scar assessment.
Detailed description
Secondary cicatricial alopecia is characterized by permanent destruction of hair follicles resulting from trauma, burns, infection, radiation, or other non-follicular pathological processes. Hair transplantation using follicular unit extraction (FUE) is an established surgical treatment for stable secondary cicatricial alopecia; however, graft survival and cosmetic outcomes may be compromised by fibrosis, reduced vascularity, and poor tissue elasticity within scarred recipient sites. Fractional carbon dioxide (CO₂) laser has been suggested to improve scar quality by promoting tissue remodeling, neovascularization, and wound healing, potentially enhancing the recipient bed before hair transplantation. Platelet-rich plasma (PRP), which contains a high concentration of growth factors, may further improve graft survival and hair growth by stimulating tissue regeneration.
This prospective comparative clinical study was conducted to evaluate whether preoperative fractional CO₂ laser treatment improves the outcome of FUE hair transplantation combined with intraoperative PRP injection in patients with stable secondary cicatricial alopecia. Twenty participants of both sexes with stable secondary cicatricial alopecia and realistic treatment expectations were enrolled. Patients with chronic systemic diseases, pregnancy or lactation, platelet or blood disorders, history of keloid formation, scar duration less than one year, or inadequate donor sites were excluded. The study was approved by the Research Ethics Committee of Tanta University Hospitals (Approval No. 34430/1/21), and written informed consent was obtained from all participants before enrollment.
Participants were assigned into two treatment groups. Group A received three sessions of fractional CO₂ laser treatment at one-month intervals before surgery, followed one month later by FUE hair transplantation combined with intraoperative PRP injection. Group B underwent direct FUE hair transplantation combined with intraoperative PRP injection without preoperative laser treatment. PRP was prepared from autologous venous blood using a double-centrifugation technique and injected into the recipient scar tissue during the transplantation procedure. Hair grafts were harvested using the FUE technique from the donor area and transplanted into the scarred recipient site according to standard surgical protocols.
Participants were followed for nine months after hair transplantation. Clinical assessment included standardized photographic evaluation by three blinded dermatologists and two plastic surgeons. Dermoscopic examination was performed before and after treatment to evaluate follicular regeneration and the percentage of scar surface covered by growing hair. Patient satisfaction and scar severity were also assessed using validated scar assessment scales. The primary objective was to determine whether preoperative fractional CO₂ laser enhances the clinical outcome of FUE hair transplantation with intraoperative PRP in patients with secondary cicatricial alopecia. Secondary objectives included evaluation of dermoscopic hair regrowth, patient satisfaction, and changes in scar assessment scores
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| fractional plus hair transplantation and PRP | Active comparator | Procedure: hair transplantation preceded by fractional and PRPTreatment injection |
| Hair transplantation plus PRP | Placebo comparator | Procedure: hair transplantation preceded by fractional and PRPPLACEBO |
Who may qualify
- Ages
- 16 to 30 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- Patients with stable secondary cicatricial alopecia. Male or female participants. Participants with realistic expectations regarding treatment outcomes. All hair types (silky, curly, or normal hair). Presence of an adequate donor site for follicular unit extraction (FUE). Ability and willingness to provide written informed consent.
Key exclusion criteria (1 listed)
- Extremes of age. Chronic systemic diseases, including hepatic or renal disease. Receiving chemotherapy or systemic corticosteroid therapy. Platelet disorders or other blood disorders. Pregnancy or lactation. History of keloid formation. Scar duration less than 1 year. Absence of a suitable donor site for hair transplantation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| hair transplantation preceded by fractional and PRPintervention injection | Procedure or surgery | Hair transplantation plus PRP, fractional plus hair transplantation and PRP |
Primary outcome
Clinical improvement after hair transplantation
Time frame: 9 months after follicular unit extraction (FUE) hair transplantation
Excellent (>75% improvement) Good (50-75%) Fair (25-49%) Poor (<25%)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Hair Transplantation
Not yet recruiting
Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE)
Androgenetic Alopecia, Cicatricial Alopecia
Not yet recruiting
The Role of Gut and Skin Microbiota in Alopecia Areata
Alopecia Areata, Fecal Microbiota Transplantation (FMT)
RecruitingPhase 2
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Alopecia Areata, Alopecia Totalis
Recruiting
A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
Hair Transplantation, Seborrheic Dermatitis
Not yet recruiting
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
Androgenic Alopecia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing hair transplantation preceded by fractional and PRP in people with Hair Transplantation, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical improvement after hair transplantation (time frame: 9 months after follicular unit extraction (FUE) hair transplantation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.